Name
Innovation or Exclusion? Antitrust, Patents and Data in the Next Era of Drug Development
Date & Time
Wednesday, October 21, 2026, 2:30 PM - 3:30 PM
Scott Hemphill Kira Stearns Christopher Wilson
Description
  • Key takeaways from the Amitiza verdict – what does it mean for future enforcement?
  • Can the proposed ETHIC Act unlock competition in pharmaceuticals by limiting patent thickets, or will it create unintended consequences for R&D?
  • The evolving development between IP rights and antitrust enforcement in life sciences
Session Type
Panel